SinuNase Phase 3 show almost 100 percent of chronic sinusitis cases are from fungal-induced inflamma
Omschrijving
Accentia Biopharmaceuticals announces evidence that most, if not all cases of chronic sinusitis, are due to a fungal-induced inflammation as originally proposed by investigators at the Mayo Clinic. The data were collected as part of the company's ongoing pivotal phase 3 clinical trial for its lead pharmaceutical product, SinuNase™, an intranasal formulation of the antifungal amphotericin B 0.01 percent suspension.
[ Ga naar het volledige artikel toe ]
Categorie: schimmel - sinusitis
[Reinig uw lichaam met de Chlorella alg -
100% plantaardig ]
|